Live
- Sharad Pawar makes a soul-stirring plea 'to regain the glory of progressive Maharashtra'
- Seven soldiers killed in attack on Pak military camp in Balochistan
- ICC announces 2025 Men’s Champions Trophy tour to begin in Islamabad
- Americans increasingly vote along class lines, not racial ones: Report
- Chandrababu's brother Rammurthy Naidu Passes Away in Hyderabad
- Russia restricts enriched uranium exports to US
- South African President orders immediate closure of tuck shops linked to food poisoning cases
- Study explains mechanisms behind food poisoning, gut infections
- Telangana residential school student commits suicide
- Cases of 'walking pneumonia' rise in US capital, joining national trend
Dr Reddy’s responds to USFDA on quality issues
City-based Dr Reddy\'s Laboratories on Wednesday said it had submitted a response to the US health regulator on a warning letter it had received last month.
Hyderabad: City-based Dr Reddy's Laboratories on Wednesday said it had submitted a response to the US health regulator on a warning letter it had received last month.
"We would like to inform that the company has submitted a response to the US Food and Drug Administration (USFDA) on December 7", the pharma major said in a release.
Last month, the company received a warning letter from the USFDA relating to quality control issues at two of its API manufacturing plants and a formulation plant in Andhra Pradesh and Telangana.
In the warning letter, the US health regulator had asked the drug maker to provide a comprehensive evaluation of the extent of inaccuracies in recorded and reported data and include a detailed action plan to fully investigate the scale and root causes of ‘deficient documentation and data management practices’.
